Autologous Human Umbilical Cord Blood(AdventHealth)(Autologous Human Umbilical Cord Blood(AdventHealth))

概要

基本信息

药物类型

细胞疗法

别名-

靶点-

作用方式-

作用机制

细胞替代物

治疗领域

神经系统疾病心血管疾病

在研适应症-

非在研适应症

缺血性卒中围手术期缺血

原研机构

Adventist Health System Sunbelt Healthcare Corp.

在研机构-

非在研机构

AdventHealth Waterman

权益机构-

最高研发阶段暂停临床1/2期

首次获批日期-

最高研发阶段(中国)-

特殊审评-

登录后查看时间轴

关联

3

项与 Autologous Human Umbilical Cord Blood(AdventHealth) 相关的临床试验

NCT02460484

/ Suspended临床1/2期IIT

Safety of Autologous Human Umbilical Cord Blood Treatment for Perinatal

Autologous human umbilical cord blood (hUCB) stored at Cord Blood Registry will be given to children who have suffered from a Perinatal Arterial Ischemic Stroke. The aim is to determine if hUCB infusion is safe, if late functional outcome is improved, if hUCB treatment improves physiologic response in the child's SSEP & EEG, and the effect of hUCB infusion in altering anatomic findings on MRI.

开始日期2015-04-01

申办/合作机构

AdventHealth Waterman

[+1]

NCT02038972

/ Completed临床1/2期IIT

Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss

To determine if autologous human umbilical cord blood infusion in children with acquired hearing loss is safe, feasible, improves inner ear function, audition and language development.

开始日期2013-01-01

申办/合作机构

AdventHealth Waterman

[+1]

NCT01328860

/ Terminated临床1期IIT

Safety of Autologous Stem Cell Treatment for Spinal Cord Injury in Children

The purpose of this research study is:
1. To see if Bone Marrow Cell harvest and transplantation are safe in children with Spinal Cord Injury, and
2. To determine if late functional outcome is improved following Bone Marrow Cell transplantation in children with Spinal Cord Injury, using pre-transplantation spinal cord function as the control.

开始日期2011-04-01

申办/合作机构